ராபர்ட் ஹாஸர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ராபர்ட் ஹாஸர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ராபர்ட் ஹாஸர் Today - Breaking & Trending Today

PharmaTher Announces FDA Approval of Ketamine IND In The


PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson’s Disease
May 17, 2021 07:59 ET
| Source:
PharmaTher Holdings Ltd.
PharmaTher Holdings Ltd.
Vancouver, British Columbia, CANADA
TORONTO, May 17, 2021 (GLOBE NEWSWIRE) PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM) (OTCQB: PHRRF), a psychedelics biotech company, is pleased to announce that the U.S. Food and Drug Administration (“FDA”) has approved the Company’s Investigational New Drug (“IND”) application to proceed with a Phase 2 clinical trial to evaluate the safety, efficacy and pharmacokinetics of ketamine in the treatment of levodopa-induced dyskinesia in patients with Parkinson’s disease (“LID-PD”).   PharmaTher expects to begin enrolling patients in the Phase 2 clinical trial in Q3-2021. Assuming the Phase 2 clinical trial is positive, the Company will request a meeting wi ....

Robert Hauser , Scott Sherman , Alberto Espay , Torsten Falk , Fabio Chianelli , Pharmather Holdings Ltd , University Of Cincinnati , University Of South Florida , Company Investigational New Drug , Company Or Pharmather , Drug Administration , University Of Arizona , Mother Holdings , Investigational New Drug , Chief Executive Officer , Active Placebo Controlled Trial , Sub Anesthetic Ketamine , Treat Levodopa Induced Dyskinesia , Unified Dyskinesia Rating Scale , Total Objective Scores , Levodopa Induced Dyskinesias , Canadian Stock Exchange Phrm Cn , Pharmather Holdings Ltd , ராபர்ட் ஹாஸர் , ஸ்காட் ஷெர்மன் , பல்கலைக்கழகம் ஆஃப் ஸிந்ஸந்யாடீ ,